Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Starting your investment journey? Learn what to watch out for as a new investor to avoid common pitfalls and make wise choices.
27,493 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Volatility hit iran international small caps hard, but history shows patient portfolios can turn shocks into opportun...
SSR Mining just sold its Copler Mine stake for $1.5 billion. This move reshapes its balance sheet, shifts portfolio r...
Palantir sits at the intersection of data software, government work, and commercial growth. Is it a palantir: risky i...
Mind Robotics has rapidly transformed Rivian's focus, reaching a multi-billion dollar valuation. Learn the two key wa...
In 2026, the VanEck Semiconductor ETF surprised many investors with standout performance. The real story isn’t just A...
Medicare’s new $2,000 out-of-pocket cap on Part D drugs is delivering real relief for retirees, with insulin costs ca...
Already own rental property but not seeing the cash flow you want? Learn proven strategies to your cash flow more by ...
Two software powerhouses offer very different paths: a hospitality-focused platform and a broad CRM suite. This guide...
As Daré gears up to discuss Q1 2026 results, investors will scrutinize cash runway, pipeline milestones, and strategi...
As SpaceX eyes a historic float, investors are handed a high-stakes mix of dream-scale growth and sobering risk. This...
When a blue-chip name like Microsoft moves, it can shake nerves and portfolios. This guide explains why microsoft sto...